Tumor-specific biology, diagnosis, and therapy

Area of Science:

• Pediatric neuro-oncology
• Cancer genomics
• Epigenetics

Background:

• Pediatric high-grade gliomas (pHGGs) and diffuse midline gliomas (DMGs) are aggressive childhood brain tumors.
• Distinct molecular and epigenetic profiles (e.g., H3K27M, H3G34R/V mutations) differentiate pediatric gliomas from adult types.
• Current treatments like radiotherapy and chemotherapy offer limited efficacy.

Purpose of the Study:

• To review recent advances in understanding the molecular and epigenetic landscape of pHGGs and DMGs.
• To discuss novel therapeutic strategies and diagnostic technologies.
• To highlight future directions for improving outcomes in these pediatric brain tumors.

Main Methods:

• Genomic, epigenomic, and transcriptomic profiling.
• DNA methylation profiling and enhancer landscape analysis.
• Liquid biopsy technologies for diagnostics and monitoring.

Main Results:

• Refined diagnostic classifications based on molecular alterations.
• Improved understanding of tumor heterogeneity and identification of therapeutic targets.
• Emerging strategies show promise but face challenges like blood-brain barrier penetration and immune evasion.

Conclusions:

• Personalized, molecularly targeted approaches are crucial for improving outcomes.
• Interdisciplinary collaboration, advanced preclinical models, and adaptive clinical trials are essential for future progress.
• Integrating multi-omic data and novel technologies will transform diagnosis and treatment.